McLean Signature Recovery Programs - Borden Cottage
235 Bayview Street, Camden, Maine, 04843
Harvard Medical School-affiliated McLean Borden Cottage specializes in residential treatment plans that address the primary addiction as well as accompanying co-occurring psychiatric disorders. As part of our Signature Recovery Programs, McLean Borden Cottage is a self-pay residential program providing unparalleled treatment in an unsurpassed setting. Our clinicians are experts in substance abuse recovery, rehabilitation and relapse prevention. They help to motivate individuals in their care to take the necessary steps to overcome addiction.
- Expert, Harvard Medical School trained clinicians supervise treatment.
- Intensive on-site diagnostic assessment including medication evaluation and management.
- Effective recovery and rehabilitation approach to alcohol and drug addiction and co-occurring conditions.
Cognitive Behavioral Therapy (CBT)The focus of cognitive behavioral therapy (also called CBT) is helping people to understand the thoughts and emotions that underlie their addiction with the goal of learning new, healthier and more productive ways to understand and express themselves.
Individual TherapyThis term describes one-on-one therapy, in which a patient and trained counselor, social worker, psychologist or psychiatrist meets privately with a patient to discuss challenges related to lifestyle, work, family and romantic relationships that may have contributed to the development of an addiction.
Meet the Staff
- Frederick Goggans, MDMedical Director, Borden Cottage, Lecturer, Harvard Medical SchoolDr. Goggans oversees a team of professionals providing residential treatment for patients with alcohol and other addictions, many of whom present with co-occurring psychiatric disorders. He is a distinguished life fellow of the American Psychiatric Association and a lecturer on psychiatry at Harvard Medical School.
- Roger D. Weiss, MDChief, Division of Alcohol and Drug Abuse; Director, Alcohol and Drug Abuse Clinical Research Program, Professor of Psychiatry, Harvard Medical SchoolDr. Weiss’ career has focused on treatment and clinical research with substance-dependent patients. He has received numerous NIH grants, developing integrated group therapy, an evidence-based treatment for co-occurring bipolar and substance use disorders, and leading a multi-site treatment study of prescription opioid dependence. He has authored over 300 publications, including several books, and was vice chair of the American Psychiatric Association Task Force on Practice Guidelines for Patients with Substance Use Disorders.